Weaving Wellness: Inside Amrutanjan's New State-of-the-Art Telangana Plant

Amrutanjan Health Care commissions its new 150 crore rupee sanitary napkin facility in Telangana to scale up production capacity and meet growing hygiene demand.

Expansion of Women’s Hygiene Manufacturing in Telangana

HYDERABAD — Fast-moving consumer goods (FMCG) major Amrutanjan Health Care Limited has officially commissioned its new, advanced sanitary napkin manufacturing facility located in Seetharampur Village, Telangana. Backed by a strategic capital investment of 150 billion rupees (1.50 billion rupees / 150 crore rupees), the new plant marks the company's fifth manufacturing unit.

According to corporate disclosures, the newly operational facility is equipped with automated Japanese technology designed to streamline high-speed production. The factory aims to roll out an estimated 700 million sanitary napkins annually, significantly boosting the company’s supply chain capabilities for its popular feminine hygiene brands.

Strategic Production Scaling and Regional Employment

The establishment of the Telangana facility aligns with Amrutanjan's long-term growth blueprint to transition from a legacy pain-management brand into a broader diversified wellness and hygiene provider. By localizing advanced manufacturing lines, the company can efficiently service escalating domestic consumption while controlling logistics overheads.

Furthermore, the industrial project has generated approximately 350 direct jobs, offering localized economic stimulus and technical skills training for regional manufacturing workers in Telangana.

Impact on Consumers, Retail Markets, and Investors

For retail consumers, the scaled-up local production ensures consistent product availability and high-quality hygiene standards across urban and rural retail networks.

For institutional investors and market observers, the 150-crore investment demonstrates prudent capital deployment, leveraging internal accruals and financial reserves to capture expanding secular demand within India’s fast-growing women's health and personal care sector.

Official Sources Section

Capital expenditure metrics, facility capacities, and operational disclosures are based on official corporate press announcements, regulatory filings, and corporate statements released by Amrutanjan Health Care Limited, with industry tracking via ScanX and The Indian Pharma Post.

Quote Section

"According to official company statements and corporate disclosures released by Amrutanjan Health Care, the commissioning of the advanced Telangana manufacturing plant will substantially expand production output to 700 million sanitary napkins annually while strengthening the company's footprint in the personal hygiene segment."

Why It Matters

Expanding domestic manufacturing capacity for essential health and hygiene products is critical for improving affordability and accessibility across emerging markets. Amrutanjan's new facility highlights how established Indian FMCG companies are modernizing supply chains through advanced automation to support public health and wellness standards.

Key Facts at a Glance

• Investment Value: Total capital outlay of 150 crore rupees (1.50 billion rupees).

• Facility Location: Seetharampur Village, Telangana.

• Production Capacity: Designed to manufacture 700 million sanitary napkins annually.

• Employment Impact: Creates approximately 350 direct jobs in the region.

• Technology Integration: Utilizes advanced automated Japanese manufacturing systems.

FAQ Section

Where is Amrutanjan's new sanitary napkin facility located?

The new manufacturing plant is situated in Seetharampur Village, Telangana.

What is the financial value of the new manufacturing project?

The facility was established with a total capital investment of 150 crore rupees.

What is the projected annual output of the new plant?

The facility is engineered to produce approximately 700 million sanitary napkins annually.

How many jobs were created by this expansion?

The plant's commissioning has generated around 350 direct employment opportunities locally.

Source: Amrutanjan Health Care Limited, ScanX, The Indian Pharma Post